Literature DB >> 11212868

Effect of ovarian hormones on intestinal mast cell reactivity to substance P.

S Bradesi1, H Eutamene, V Theodorou, J Fioramonti, L Bueno.   

Abstract

Evidence exists to support the concept that ovarian hormones influence mast cell functioning and related events. Here, we evaluated the constitutive gender difference and the influence of ovarian status on rat mast cell (MC) distribution in jejunum and colon, histamine synthesis and/or its release elicited by Substance P (SP). Higher mast cell (MC) number and histamine release were found in female compared with male. In female rats, hormonal status did not affect the density of resident MC neither in the jejunum nor in the colon. Interestingly, histamine levels released after SP stimulation of jejunal segment was reduced in ovariectomized (OVX) compared with sham OVX rats, and restored in OVX female receiving progesterone. In the colon, OVX resulted in a significant increase in histamine levels released after SP stimulation and a treatment with progesterone did not restore basal histamine levels. Thus, ovarian steroid hormones do not affect jejunal and colonic mast cell number. However, the hormonal status differently influences jejunal and colonic MC sensitivity to SP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212868     DOI: 10.1016/s0024-3205(00)01008-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Visceral perception: inflammatory and non-inflammatory mediators.

Authors:  L Bueno; J Fioramonti
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Anti-superoxide and anti-peroxynitrite strategies in pain suppression.

Authors:  Kali Janes; William L Neumann; Daniela Salvemini
Journal:  Biochim Biophys Acta       Date:  2011-12-19

3.  Regular exercise modulates cardiac mast cell activation in ovariectomized rats.

Authors:  Sukanya Phungphong; Anusak Kijtawornrat; Jonggonnee Wattanapermpool; Tepmanas Bupha-Intr
Journal:  J Physiol Sci       Date:  2015-10-14       Impact factor: 2.781

4.  Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.

Authors:  P J Hesketh; S M Grunberg; J Herrstedt; R de Wit; R J Gralla; A D Carides; A Taylor; J K Evans; K J Horgan
Journal:  Support Care Cancer       Date:  2006-02-01       Impact factor: 3.603

Review 5.  Have We Just Scratched the Surface? A Narrative Review of Uremic Pruritus in 2020.

Authors:  Claire E Martin; Sergi Clotet-Freixas; Janine F Farragher; Gregory L Hundemer
Journal:  Can J Kidney Health Dis       Date:  2020-10-15

Review 6.  Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.

Authors:  K Janes; A M Symons-Liguori; K A Jacobson; D Salvemini
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

7.  Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.

Authors:  Kali Janes; Carrie Wahlman; Joshua W Little; Timothy Doyle; Dillip K Tosh; Kenneth A Jacobson; Daniela Salvemini
Journal:  Brain Behav Immun       Date:  2014-09-08       Impact factor: 7.217

8.  Gender-related effects of sex steroids on histamine release and FcεRI expression in rat peritoneal mast cells.

Authors:  Samira Muñoz-Cruz; Yolanda Mendoza-Rodríguez; Karen E Nava-Castro; Lilián Yepez-Mulia; Jorge Morales-Montor
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

9.  Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats.

Authors:  Ju Yup Lee; Nayoung Kim; Yong Sung Kim; Ryoung Hee Nam; Min Hee Ham; Hye Seung Lee; Wonjun Jo; Youngkwang Shim; Yoon Jin Choi; Hyuk Yoon; Cheol Min Shin; Dong Ho Lee
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.